Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150K 300K 450K Q1 '12: 0 Q2 '12: 0 Q3 '12: 0 Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 22K Q1 '14: 23K Q2 '14: 23K Q3 '14: 2K Q4 '14: 45K Q1 '15: 0 Q2 '15: 73K Q3 '15: 37K Q4 '15: 8K Q1 '16: 0 Q2 '16: 28K Q3 '16: 26K Q4 '16: 28K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '23: 40K Q4 '23: 63K Q1 '24: 57K Q2 '24: 56K Q3 '24: 59K Q4 '24: 258K Q1 '25: 45K Q2 '25: 317K Q3 '25: 123K Q4 '25: 219K Q1 '26: 226K Q2 '26: 414K Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '20 Q4 '21 Q3 '24 Q2 '26

Gross Profit Quarterly

-90K -60K -30K 0 30K 60K 90K Q1 '12: 0 Q2 '12: 0 Q3 '12: 0 Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 11K Q1 '14: 11K Q2 '14: 11K Q3 '14: 1K Q4 '14: 22K Q1 '15: 0 Q2 '15: 36K Q3 '15: 19K Q4 '15: -76K Q1 '16: 0 Q2 '16: -16K Q3 '16: 13K Q4 '16: -31K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q3 '12 Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '12: -1.3M Q2 '12: -1.8M Q3 '12: -1.7M Q4 '12: -2M Q1 '13: -2M Q2 '13: -2.1M Q3 '13: -2.1M Q4 '13: -2.6M Q1 '14: -3M Q2 '14: -2.5M Q3 '14: -2.7M Q4 '14: -2.8M Q1 '15: -2.6M Q2 '15: -4.5M Q3 '15: -2.3M Q4 '15: -2.3M Q1 '16: -2.5M Q2 '16: -2.9M Q3 '16: -3.1M Q4 '16: -3.6M Q1 '17: -3M Q2 '17: -3.7M Q3 '17: -3.3M Q4 '17: -1.4M Q1 '18: -1.5M Q2 '18: -2M Q3 '18: -2.2M Q4 '18: -2.1M Q1 '19: -2M Q2 '19: -2.7M Q3 '19: -2.5M Q4 '19: -1.7M Q1 '20: -1.9M Q2 '20: -1.3M Q3 '20: -1.1M Q4 '20: -1.1M Q1 '21: -995K Q2 '21: -918K Q3 '21: -822K Q4 '21: -5.9M Q1 '22: -2.2M Q2 '22: -1.4M Q3 '22: -1.1M Q4 '22: -1.5M Q1 '23: -2.9M Q2 '23: -2.7M Q3 '23: -1.6M Q4 '23: -1.8M Q1 '24: -2M Q2 '24: -2.5M Q3 '24: -1.9M Q4 '24: -1.4M Q1 '25: -1.7M Q2 '25: -1.8M Q3 '25: -1.7M Q4 '25: -1.7M Q1 '26: -1.6M Q2 '26: -1.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '12: -1.3M Q2 '12: -1.8M Q3 '12: -1.7M Q4 '12: -2M Q1 '13: -2M Q2 '13: -2.1M Q3 '13: -2.1M Q4 '13: -2.6M Q1 '14: -3M Q2 '14: -2.5M Q3 '14: -2.7M Q4 '14: -2.8M Q1 '15: -2.6M Q2 '15: -4.5M Q3 '15: -2.3M Q4 '15: -2.3M Q1 '16: -2.5M Q2 '16: -2.7M Q3 '16: -3.1M Q4 '16: -3.3M Q1 '17: -3.8M Q2 '17: -3.6M Q3 '17: -3.2M Q4 '17: -1.2M Q1 '18: -1.5M Q2 '18: -2.1M Q3 '18: -2.1M Q4 '18: -1.8M Q1 '19: -1.9M Q2 '19: -2.4M Q3 '19: -2.4M Q4 '19: -1.6M Q1 '20: -2M Q2 '20: -1.2M Q3 '20: -660K Q4 '20: -1M Q1 '21: -874K Q2 '21: -382K Q3 '21: -849K Q4 '21: -5.9M Q1 '22: -2.2M Q2 '22: -1.3M Q3 '22: -1.1M Q4 '22: -1.5M Q1 '23: -2.9M Q2 '23: -2.6M Q3 '23: -1.6M Q4 '23: -1.8M Q1 '24: -2M Q2 '24: -2.5M Q3 '24: -1.9M Q4 '24: -1.3M Q1 '25: -1.7M Q2 '25: -1.8M Q3 '25: -1.7M Q4 '25: -1.7M Q1 '26: -1.6M Q2 '26: -1.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q1 '12: 0 Q2 '12: 0 Q3 '12: 0 Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 11K Q1 '14: 12K Q2 '14: 12K Q3 '14: 1K Q4 '14: 23K Q1 '15: 0 Q2 '15: 37K Q3 '15: 18K Q4 '15: 84K Q1 '16: 0 Q2 '16: 44K Q3 '16: 13K Q4 '16: 59K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '24: 12K Q2 '24: 13K Q3 '24: 70K Q4 '24: 175K Q1 '25: 33K Q2 '25: 302K Q3 '25: 112K Q4 '25: 199K Q1 '26: 206K Q2 '26: 391K Q4 '12 Q1 '14 Q2 '15 Q3 '16 Q4 '17 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '13: -1.9M Q2 '13: -1.9M Q3 '13: -1.8M Q4 '13: -2.1M Q1 '14: -1.4M Q2 '14: -2.4M Q3 '14: -1.9M Q4 '14: -2.3M Q1 '15: -1.7M Q2 '15: -2M Q3 '15: -1.9M Q4 '15: -1.6M Q1 '16: -2.5M Q2 '16: -1.5M Q3 '16: -2.1M Q4 '16: -3M Q1 '17: -3.1M Q2 '17: -3.1M Q3 '17: -3.2M Q4 '17: -1.7M Q1 '18: -2.1M Q2 '18: -1.2M Q3 '18: -2.2M Q4 '18: -2.2M Q1 '19: -1.2M Q2 '19: -2M Q3 '19: -1.4M Q4 '19: -1.4M Q1 '20: -1.1M Q2 '20: -1.1M Q3 '20: -855K Q4 '20: -1M Q1 '21: -560K Q2 '21: -613K Q3 '21: -454K Q4 '21: -1M Q1 '22: -519K Q2 '22: -1.1M Q3 '22: -1.7M Q4 '22: -1.7M Q1 '23: -1M Q2 '23: -1.5M Q3 '23: -3.2M Q4 '23: -1.2M Q1 '24: -960K Q2 '24: -1.3M Q3 '24: -1.5M Q4 '24: -1.1M Q1 '25: -758K Q2 '25: -941K Q3 '25: -1.5M Q4 '25: -664K Q1 '26: -937K Q2 '26: -569K Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q1 '13: -1.9M Q2 '13: -1.9M Q3 '13: -1.9M Q4 '13: -2.2M Q1 '14: -1.7M Q2 '14: -2.7M Q3 '14: -2.4M Q4 '14: -2.5M Q1 '15: -1.7M Q2 '15: -2M Q3 '15: -2M Q4 '15: -1.6M Q1 '16: -2.6M Q2 '16: -1.6M Q3 '16: -2.1M Q4 '16: -3.1M Q1 '17: -3.2M Q2 '17: -3.2M Q3 '17: -3.2M Q4 '17: -1.7M Q1 '18: -2.1M Q2 '18: -1.3M Q3 '18: -2.3M Q4 '18: -2.2M Q1 '19: -1.2M Q2 '19: -2.1M Q3 '19: -1.4M Q4 '19: -1.5M Q1 '20: -1.1M Q2 '20: -1.1M Q3 '20: -862K Q4 '20: -1M Q4 '21: -1M Q3 '22: -1.7M Q1 '23: -1M Q2 '23: -1.5M Q3 '23: -3.2M Q4 '23: -1.2M Q3 '13 Q4 '14 Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q4 '21 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3.5B 7B 10.5B Q3 '20: 8.9B Q1 '21: 9.4M Q2 '21: 9.7M Q3 '21: 10M Q1 '22: 10.8M Q2 '22: 11.2M Q3 '22: 11.6M Q1 '23: 12.2M Q2 '23: 13.8M Q3 '23: 13.9M Q1 '24: 13.9M Q2 '24: 14.3M Q3 '24: 15M Q1 '25: 15.9M Q2 '25: 15.9M Q3 '25: 17M Q1 '26: 17.6M Q2 '26: 17.6M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-12.00 -8.00 -4.00 0.00 4.00 8.00 12.00 Q4 '12: -0.86 Q1 '13: -0.96 Q2 '13: -1.00 Q3 '13: -1.05 Q4 '13: -1.14 Q1 '14: -1.27 Q2 '14: -1.32 Q3 '14: -1.39 Q4 '14: -1.41 Q1 '15: -1.41 Q2 '15: -1.53 Q3 '15: -1.38 Q4 '15: -1.19 Q1 '16: -0.98 Q2 '16: -0.71 Q3 '16: -0.70 Q4 '16: -4.44 Q1 '17: -7.09 Q2 '17: -8.86 Q3 '17: -10.34 Q4 '17: -7.04 Q1 '18: -4.77 Q2 '18: -3.38 Q3 '18: -2.09 Q4 '18: -1.77 Q1 '19: -1.53 Q2 '19: -1.35 Q3 '19: -1.31 Q4 '19: -1.21 Q1 '20: -1.13 Q2 '20: -0.90 Q3 '21: -0.31 Q4 '21: -0.78 Q1 '22: -0.89 Q2 '22: -0.97 Q3 '22: -0.99 Q4 '22: -0.55 Q1 '23: -0.59 Q2 '23: -0.66 Q3 '23: -0.68 Q4 '23: -0.68 Q1 '24: -0.59 Q2 '24: -0.58 Q3 '24: -0.58 Q4 '24: -0.53 Q1 '25: -0.48 Q2 '25: -0.41 Q3 '25: -0.39 Q4 '25: -0.41 Q1 '26: -0.40 Q2 '26: -0.39 Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '20 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.